IntegratedRx supports point-of-care dispensing by partnering with health systems so oral oncology and cystic fibrosis therapies can be dispensed within the patients ...

After a strong start to the year, the value of biotech financings has tailed off a little, but March has seen a clutch of $50 ...

Stock market updates: futures slip as Hormuz reopening talks lift focus.

Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer: Results From the Randomized ...

Executives from CG Oncology (NASDAQ:CGON) outlined clinical results, ongoing trials, and launch preparations for its investigational intravesical therapy cretostimogene (referred to as “Credo”) during ...

In this 5-year follow-up from the CheckMate 743 study in patients with unresectable pleural mesothelioma (PM), we evaluated updated efficacy and safety outcomes and biomarkers and performed ...

Tanzania is stepping up its fight against cancer through a strategic partnership that could redefine how the disease is ...

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

The oncology monoclonal antibodies market presents opportunities through technological advancements, new product launches, and growing patient awareness. Expanding cancer prevalence, innovative drug ...

Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancerTransformative moment in ...

Fewer older women with early-stage, hormone receptor (HR)-positive, HER2-negative breast cancer are undergoing routine sentinel lymph node biopsy (SLNB), according to data that were presented at the ...

The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...